TARGET (CT-FFR)
2023
On-Site Computed Tomography-Derived Fractional Flow Reserve to Guide Management of Patients with Stable Coronary Artery Disease: the TARGET Randomized Trial
In 1,216 patients with stable coronary disease and an intermediate stenosis on CT angiography, an on-site machine-learning CT-FFR care pathway reduced invasive angiography without obstructive disease or intervention within 90 days compared with standard care.
Result
- Absolute difference
- 17.9 points
- NNT
- 6
Absolute difference and NNT are derived from the event rates.
Also reported: Invasive angiography in 69.2% vs 79.4%; revascularisation 49.7% (302/608) vs 42.8% (260/608) (P=0.02); 1-year MACE HR 0.88 (95% CI 0.59–1.30); quality of life and symptoms improved similarly.
- Subtopic
- CT & coronary physiology
- Design
- Multicentre RCT, China (6 centres)
- Relevance
- Important: one of several pillars.
- Source
- Yang J, et al. Circulation. 2023;147(18):1369-1381.doi 10.1161/CIRCULATIONAHA.123.063996
Discussion & critique
The first RCT of on-site machine-learning CT-FFR as a care pathway: it met its primary endpoint by cutting non-actionable invasive angiograms, but revascularisation increased overall without any improvement in symptoms, quality of life or 1-year MACE. Both results need saying together. Open-label, a process endpoint, and a cost trend (−4,233 yuan, P=0.07) that did not reach significance; whether the extra revascularisation helped or harmed is unanswered at one year.